Utama › Kanser Prostat › Florida › Orlando
Kajian klinikal Kanser Prostat di Orlando, FL
17 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi jauh
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Mengambil pesertaFasa 2/3
- AdventHealth, Orlando
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Mengambil pesertaFasa 3
- AdventHealth, Orlando
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Mengambil pesertaFasa 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Mengambil pesertaFasa 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Mengambil peserta
- AdventHealth, Orlando
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
Mengambil pesertaFasa 1/2
- Research Site, Orlando
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute @ Florida Cancer, Orlando
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Research Site, Orlando
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
Mengambil pesertaFasa 1
- AdventHealth Orlando, Orlando
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Florida Cancer Specialists & Research Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · 17 mi jauh
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Adventhealth, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #8, Orlando
Exploring the Potential of Robotic Telesurgery in Remote Settings
Mengambil peserta
- AdventHealth, Celebration · 17 mi jauh
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Mengambil pesertaFasa 2
- AdventHealth, Orlando
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Orlando
- Kanser Paru-paru Bukan Sel Kecil44 kajian
- Obesiti31 kajian
- Kanser Metastatik29 kajian
- Berat Badan Berlebihan27 kajian
- Penyakit Alzheimer25 kajian
- Diabetes Jenis 224 kajian
- Kanser (semua jenis)24 kajian
- Kanser Payudara23 kajian
- Kanser Ovari22 kajian
- Kolitis Ulseratif22 kajian
- Kanser Paru-paru21 kajian
- Kanser Kolorektal19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.